PattersonCompanies (PDCO)

Patterson Companies, Inc. (Nasdaq: PDCO) today reported operating results for its fiscal 2025 third quarter ended January 25, 2025.

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Patterson Companies, Inc. (NASDAQPDCO) to Patient Square Capital for $31.35 in cash per share is fair to Patterson shareholders.

Patterson Companies, Inc. (Nasdaq: PDCO), a leading dental and animal health distributor, today announced the expiration of the 40-day “go-shop” period under the terms of the previously announced definitive merger agreement, pursuant to which Patient Square Capital, L.P. (“Patient Square”), a dedicated health care investment firm, will acquire Patterson for $31.35 per share, in an all-cash transaction valued at approximately $4.1 billion, including the refinancing of Patterson’s receivables facilities. The “go-shop” period expired at 11:59 p.m. (Central Time) on January 19, 2025.

NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

BALA CYNWYD, Pa., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

BALA CYNWYD, Pa., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

NEW YORK, Dec. 14, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

NEW YORK, NY / ACCESSWIRE / December 12, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating:

BALA CYNWYD, Pa., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

NEW YORK, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

NEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Patterson Companies, Inc. (NASDAQPDCO) to Patient Square Capital for $31.35 in cash per share is fair to Patterson shareholders.

Ademi LLP is investigating Patterson (Nasdaq: PDCO) for possible breaches of fiduciary duty and other violations of law in its transaction with Patient Square.

Patterson Companies, Inc. (Nasdaq: PDCO), a leading dental and animal health distributor, today announced that it has entered into a definitive agreement to be acquired by Patient Square Capital (Patient Square), a dedicated health care investment firm. Under the terms of the agreement, Patterson shareholders will receive $31.35 in cash per share, representing an approximately 49% premium to Patterson’s 30 calendar day volume-weighted average price (VWAP) ending December 4, 2024 (the last trading day prior to Patterson announcing the evaluation of strategic alternatives), or a transaction value of approximately $4.1 billion, including the refinancing of Patterson’s receivables facilities.

Patterson Companies, Inc. (Nasdaq: PDCO) today reported operating results for its fiscal 2025 second quarter ended October 26, 2024.

Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2025 second-quarter conference call on Thursday, December 5, 2024, at 7:30 a.m. CT (8:30 a.m. ET). The company’s earnings release will be issued that morning before the market opens.

Patterson Dental Supply, Inc., a subsidiary of Patterson Companies, Inc. (Nasdaq: PDCO), today announced an agreement in principle between Patterson and PDS Health, a leading dental and medical support organization formerly known as Pacific Dental Services, to extend their strategic relationship through the end of 2027. The extension allows Patterson to continue as the premier distributor for all merchandise, services, technology and core equipment across PDS Health’s network of more than 1,000 supported practices nationwide.

Patterson Companies Inc. (Nasdaq: PDCO) announced the appointment of Kristin Dietzler as Patterson Dental’s North American president. Dietzler brings extensive expertise in adjacent healthcare companies with a proven track record of success in optimizing results. She will report to Kevin Pohlman, chief operating officer of Patterson Companies, and she will be a member of the company’s executive leadership team.

Patterson Companies, Inc. (Nasdaq: PDCO) a leading distribution company in the dental and animal health industries, today announced that it has signed two separate acquisition agreements for its Animal Health business – Infusion Concepts in the United Kingdom and Mountain Vet Supply in the United States.

On September 17, 2024, the Board of Directors of Patterson Companies, Inc. (Nasdaq: PDCO) declared a quarterly cash dividend of $0.26 per share. The dividend will be payable on, or about, November 1, 2024, to shareholders of record as of the close of business on October 18, 2024.

Patterson Companies, Inc. (Nasdaq: PDCO) today reported operating results for its fiscal 2025 first quarter ended July 27, 2024.

Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2025 first-quarter conference call on Wednesday, August 28, 2024, at 7:30 a.m. CT (8:30 a.m. ET). The company’s earnings release will be issued that morning before the market opens.

Patterson Companies, the trusted partner for the dental and animal health markets, announced the release of its fiscal year 2024 Corporate Responsibility Report. The report focuses on our effort as an organization to promote an inclusive workplace, reduce the company’s carbon footprint, and execute a DE&I strategy. These initiatives allow us to hold ourselves accountable and align back to the company values.

Pearl, the global leader in dental AI solutions, and Patterson Dental Canada, Inc., a subsidiary of Patterson Companies, Inc. (Nasdaq: PDCO), today announced a collaboration to expand access to Pearl’s Second Opinion® AI disease detection capabilities within the Canadian dental market.

Weave (NYSEWEAV), a leading all-in-one experience platform for small- and medium-sized healthcare businesses, and Patterson Dental Supply, Inc., a subsidiary of Patterson Companies, Inc. (Nasdaq: PDCO), today announced new integration features within Weave and the Patterson Dental practice management software solutions Fuse, Eaglesoft and Dolphin Management. These new integrations are now the deepest, most complete data exchange available in the market, with the ability to read and write patient data, appointment data and confirmations, and read and write to the ledger to facilitate payment collection.